MONTAGNANI, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 4.154
EU - Europa 3.040
AS - Asia 1.000
AF - Africa 178
SA - Sud America 19
OC - Oceania 6
Totale 8.397
Nazione #
US - Stati Uniti d'America 4.132
GB - Regno Unito 855
IT - Italia 512
SE - Svezia 451
VN - Vietnam 391
DE - Germania 384
CN - Cina 348
UA - Ucraina 199
IN - India 175
IE - Irlanda 167
FR - Francia 122
RU - Federazione Russa 112
EE - Estonia 67
ZA - Sudafrica 58
TG - Togo 54
CH - Svizzera 51
BG - Bulgaria 41
NG - Nigeria 29
JO - Giordania 25
CI - Costa d'Avorio 17
FI - Finlandia 17
SC - Seychelles 16
CA - Canada 13
BE - Belgio 12
IR - Iran 12
JP - Giappone 10
NL - Olanda 10
TR - Turchia 10
PL - Polonia 9
BR - Brasile 8
SG - Singapore 6
AT - Austria 5
DK - Danimarca 5
EC - Ecuador 5
MX - Messico 5
CZ - Repubblica Ceca 4
AR - Argentina 3
AU - Australia 3
EG - Egitto 3
GR - Grecia 3
KR - Corea 3
NZ - Nuova Zelanda 3
PK - Pakistan 3
RO - Romania 3
UZ - Uzbekistan 3
ES - Italia 2
HN - Honduras 2
ID - Indonesia 2
LB - Libano 2
MK - Macedonia 2
MY - Malesia 2
NO - Norvegia 2
PE - Perù 2
PH - Filippine 2
BZ - Belize 1
CL - Cile 1
GL - Groenlandia 1
HK - Hong Kong 1
HR - Croazia 1
IL - Israele 1
KW - Kuwait 1
LK - Sri Lanka 1
MD - Moldavia 1
MM - Myanmar 1
PT - Portogallo 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 8.397
Città #
Southend 782
Fairfield 634
Chandler 538
Ashburn 308
Houston 227
Dong Ket 219
Princeton 207
Seattle 198
Wilmington 194
Woodbridge 185
Dublin 167
Cambridge 164
Ann Arbor 141
Jacksonville 127
Bologna 111
Nanjing 77
Westminster 74
New York 64
Padova 62
Berlin 60
Lomé 54
Saint Petersburg 49
Medford 48
Bern 42
Sofia 40
Boardman 37
Jinan 33
Shenyang 31
Dearborn 30
Abeokuta 29
Milan 28
Hebei 27
San Diego 27
Amman 25
Bremen 24
Nanchang 24
Florence 23
Beijing 22
Redmond 21
Changsha 20
Pune 20
Mülheim 18
Abidjan 17
Helsinki 16
Turin 16
Des Moines 15
Jiaxing 15
Mahé 15
Mountain View 13
Redwood City 13
Falls Church 12
Norwalk 12
Tianjin 12
Brussels 11
Zhengzhou 11
Olalla 10
Torino 10
Hangzhou 9
Guangzhou 8
Lanzhou 8
London 8
Paris 8
Rome 8
San Francisco 8
Taizhou 8
Tokyo 8
Kunming 7
Monmouth Junction 7
Phoenix 7
Toronto 7
Leawood 6
Mumbai 6
Ningbo 6
Andover 5
Granarolo 5
Haikou 5
Leuchtenberg 5
Los Angeles 5
São Paulo 5
Verona 5
Bari 4
Bühl 4
Castelnuovo Rangone 4
Frankfurt am Main 4
Gualtieri 4
Hanover 4
Naples 4
Nueva Loja 4
Zanjan 4
Bolzano 3
Bra 3
Buffalo 3
Desio 3
Forlì 3
Frankfurt Am Main 3
Gangnam-gu 3
Groningen 3
Istanbul 3
Kuban 3
Lausanne 3
Totale 5.632
Nome #
A new model for portal protein profile analysis in course of ileal intraluminal bile acid infusion using an in situ perfused rat intestine. 240
Attitudes of Crohn's Disease Patients: Infodemiology Case Study and Sentiment Analysis of Facebook and Twitter Posts 196
Antiinflammatory Effect of Phytosterols in Experimental Murine Colitis Model: Prevention, Induction, Remission Study 183
Chlamydia pneumoniae acute liver infection affects hepatic cholesterol and triglyceride metabolism in mice 179
Acute Fitz-Hugh-Curtis Syndrome in a Man due to Gonococcal Infection 173
Clinical trial: modulation of human placental multidrug resistance proteins in cholestasis of pregnancy by ursodeoxycholic acid. 171
A RETROSPECTIVE STUDY ON INTRAHEPATIC CHOLESTASIS OF PREGNANCY: MARKERS OF PREMATURE DELIVERY 168
Clinical efficacy and effectiveness of ursodeoxycholic acid in cholestatic liver diseases. 160
Curcuma longa Extract Exerts a Myorelaxant Effect on the Ileum and Colon in a Mouse Experimental Colitis Model, Independent of the Anti-Inflammatory Effect 159
The future of dual therapy for hepatitis C virus 156
A Patient With Pancreas Divisum, Recurrent Acute Pancreatitis, and Homozygosity for the Cystic Fibrosis Transmembrane Regulator–Associated Protein 5T Allele 153
Correlazione materno-fetale degli acidi biliari in corso di colestasi gravidica 153
High Doses of Ursodeoxycholic Acid Up-Regulate the Expression of Placental Breast Cancer Resistance Protein in Patients Affected by Intrahepatic Cholestasis of Pregnancy 141
Generation of a novel antibody probe to the Apical Sodium-Dependent Bile Acid Transporter that inhibits ileal bile acid absorption 134
Relationship between indocyanine green retention test, decompensation and survival in patients with Child-Pugh A cirrhosis and portal hypertension 134
Alisporivir for the treatment of chronic HCV 130
Chlamydia pneumoniae replicates in Kupffer cells in mouse model of liver infection. 129
Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: a prospective study on patients with HCV related cirrhosis. 123
Curcuma longa L. as a therapeutic agent in intestinal motility disorders. 2: Safety profile in mouse. 123
Correlation between Indocyanine green retention test and esophageal varices among patients with hepatocellular carcinoma 119
Understanding Crohn's disease patients reaction to infliximab from facebook: A medical perspective 114
Severe immune thrombocytopenia after peg-interferonalpha2a, ribavirin and telaprevir treatment completion: A case report and systematic review of literature 113
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease 113
Analysis of ileal sodium/bile acid cotransporter and related nuclear receptor genes in a family with multiple cases of idiopathic bile acid malabsorption 112
Mathematical model predicting high hepatocyte proliferation index and risk of HCC in patients with HCV related cirrhosis: a proposal for clinical validation 111
Higher doses of peginterferon alpha-2b administered twice weekly improve sustained virological response in difficult-to-treat patients with chronic hepatitis C: results of a pilot randomized study 108
Production of reactive oxygen species and expression of inducible nitric oxide synthase in rat isolated Kupffer cells stimulated by Leptospira interrogans and Borrelia burgdorferi 108
Dual-color bioluminescent assay using infected HepG2 cells sheds new light on Chlamydia pneumoniae and human cytomegalovirus effects on human cholesterol 7α-hydroxylase (CYP7A1) transcription. 104
PROTON PUMP INHIBITORS: RISKS OF LONG-TERM USE 101
Noninvasive diagnosis of portal hypertension and esophageal varices through the identification of liver blood flow markers 100
Pharmacological modulation of MRP2 in primary biliary cirrhosis 98
Systemic fungemia and hepatic localizations of Fusarium solani in a liver transplanted patient: An emerging fungal agent. 97
Noninvasive Assessment of Portal Hypertension in Advanced Chronic Liver Disease: An Update 96
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease. 95
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease 93
Superior efficacy of twice a week administration of peginterferon alpha-2b plus ribavirin in obtaining SVR in HCV genotype 1 92
Hepatobiliary phospholipid transporter ABCB4, MDR3 gene variants in a large cohort of Italian women with intrahepatic cholestasis of pregnancy 91
Mathematical model predicting high hepatocyte proliferation index and risk of HCC in patients with HCV related cirrhosis: a proposal for clinical validation 91
High dose lamivudine in HBV-related cirrhotic patients with unsatisfactory response after adefovir add-on 90
Semisynthetic bile acid FXR and TGR5 agonists: Physicochemical properties, pharmacokinetics, and metabolism in the rats 88
Indocyanine green retention test as a non-invasive marker of portal hypertension and esophageal varices in compensated liver cirrhosis. 86
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease. 84
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease 84
Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis 84
The foetal-maternal circulation of bile acids and bilirubin: effects of cholestasis and UDCA administration. 83
Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis. 83
Indocyanine green clearance (ICG) as a predictor of 2-years clinical decompensation and mortality in patients with compensated liver cirrhosis 82
Genetic polymorphisms of PPAR-alpha: allele frequency in gallstone patients. 79
HIGH FREE AND GLYCOCONJUGATED AND LOW TAUROCONJUGATED BA LEVELS IN SERUM ARE THE MIRROR OF INTESTINAL EVENTS AND HEPATIC UPTAKE 79
UDCA UP-REGULATES HUMAN PLACENTAL BCRP EXPRESSION: PRELIMINARY RESULTS 79
Indocyanine Green 15-min Retention test (ICG-r15) as a predictor of clinical decompensation in patients with compensated liver cirrhosis. 78
Indocyanine Green Clearance (ICG) as a predictor of clinical decompensation and mortality in patients with compensated liver cirrhosis 78
Intestinal microflora and motility in gallstones before and after cholecystectomy: any role for gallstone pathogenesis? 77
Insulin resistance in viral hepatitis B and C and non virus related chronic hepatitis 77
Approaches to the Diagnosis of Portal Hypertension: Non-Invasive or Invasive Tests? 76
Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis. 75
null 75
INFEZIONI E INFESTAZIONI DELL’APPARATO DIGERENTE (capitolo 56) 74
Effects of UDCA on the foetus-maternal circulation of bilirubin in cholestasis of pregnancy 74
The foetal-maternal circulation of bile acids and bilirubin: effects of cholestasis and UDCA administration. 74
Reduced biliary sterol output with no change in total faecal excretion in mice expressing a human apolipoprotein A-I variant 74
Effects of UDCA on the foetus-maternal circulation of bilirubin in cholestasis of pregnancy 72
Insulin resistance in viral hepatitis B and C and non virus related chronic hepatitis 72
UDCA UP-REGULATES HUMAN PLACENTAL OATP-A EXPRESSION IN INTRAHEPATIC CHOLESTASIS OF PREGNANCY 71
Malattie colestatiche del fegato. Rapporti tra fegato e gravidanza. In: Cirrosi epatica: epidemiologia, diagnosi e terapia. 70
Infezioni, infestazioni, patologia gastroenterologica emergente dall’immigrazione (capitolo 56) 67
Effects of UDCA on the foetus-maternal circulation of bilirubin in cholestasis of pregnancy 67
null 65
Prevalence of different PPAR-alpha gene polymorphisms and haplotypes in gallstone patients. Dig Liv Dis 2005;Vol. 37 Suppl.1:S36. 64
Metabolic, nutritional and immunological parameters in healthy volunteers after inulin and saccharose feeding 63
Indocyanine green retention test predict the risk of portal hypertension-related events after direct-acting antiviral therapy in compensated advanced chronic liver disease patients 63
Treatment of acute hepatitis B with high dose lamivudine 62
Indocyanine green clearance (ICG) as a predictor of clinical decompensation and mortality in patients with compensated liver cirrhosis. 59
Effects of cholesterol 7alpha-hydroxylase promoter polymorphisms on basal promoter activity and feedback regulation of bile acid synthesis 58
Prognostic value of the albumin-bilirubin grade for the prediction of post-hepatectomy liver failure: A systematic review and meta-analysis 57
Sleisenger e Fordtran. Malattie gastrointestinali ed epatiche. Fisiopatologia, diagnosi e trattamento 57
MDR3 mutations in a large cohort of italian women with intrahepatic cholestasis of pregnancy 55
Bile acids: Physico-chemical properties, function and activity 54
Cholic acid metabolism in human fecal cultures during diet supplementation with Lactobacillus rhamnosus GG 53
Bile acid active and passive ileal transport in the rabbit: effect of luminal stirring 46
Alcolismo e patologie alcool-correlate 45
Bile acid structure and intestinal absorption in the animal model 43
A comparison of the analytical performance of sodium dodecyl sulfate-polyacrylamide gel electrophoresis, electrospray and matrix-assisted laser desorption/ionization mass spectrometry in the study of the protein extract from bothrops jararaca snake venom 42
FISIOPATOLOGIA GASTRICA 41
Production of tumor necrosis factor alpha by Treponema pallidum, Borrelia burgdorferi s.l., and Leptospira interrogans in isolated rat Kupffer cells. 37
Competition in liver transport between chenodeoxycholic acid and ursodeoxycholic acid as a mechanism for ursodeoxycholic acid and its amidates' protection of liver damage induced by chenodeoxycholic acid 36
Gastric autoimmune disorders in patients with chronic hepatitis C before, during the after interferon-alpha therapy 33
Hepatic uptake and intestinal absorption of bile acids in the rabbit 28
Long-term alpha interferon and lamivudine combination therapy in non-responder patients with anti-HBe-positive chronic hepatitis B: Results of an open, controlled trial 28
Long-term results with interferon therapy in chronic type B hepatitis: A prospective randomized trial 26
Phagocytosis of Treponema pallidum and reactive oxygen species production by isolated rat Kupffer cells 24
Absence of dysfunctional ileal sodium - Bile acid cotransporter gene mutations in patients with adult-onset idiopathic bile acid malabsorption 23
Relationship between structure and intestinal absorption of bile acids with a steroid or side-chain modification 23
Can Liver Ultrasound Elastography Predict the Risk of Hepatocellular Carcinoma Recurrence After Radiofrequency Ablation? A Systematic Review and Meta-Analysis 22
Uptake and killing of Lyme disease and relapsing fever borreliae in the perfused rat liver and by isolated Kupffer cells 22
GASTRIC PATHOPHYSIOLOGY 21
Uptake and killing of Leptospira interrogans and Borrelia burgdorferi, spirochetes pathogenic to humans, by reticuloendothelial cells in perfused rat liver 21
Intestinal absorption of bile acids in the rabbit: Different transport rates in jejunum and ileum 19
Efficacy of ursodeoxycholic acid in association with α-interferon for chronic hepatitis C in α-interferon non-responder patients 17
Lamivudine treatment for severe acute HBV hepatitis. 16
Totale 8.536
Categoria #
all - tutte 21.659
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.659


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201990 0 0 0 0 0 0 0 0 0 0 0 90
2019/20202.013 327 50 26 113 188 213 248 258 274 129 70 117
2020/20211.136 219 71 43 44 21 37 25 63 128 52 46 387
2021/20221.978 157 70 100 109 134 82 39 97 106 124 638 322
2022/20231.991 242 286 124 235 124 161 52 105 337 47 166 112
2023/2024661 34 94 33 119 50 178 30 30 36 26 23 8
Totale 8.633